Skip to content
Dose Brief
Menu
The shortlist

Alternatives to Luvo Health

Luvo Health sits at No. 42 in our ranking with a Brief Score of 79. Here are the GLP-1 providers we'd weigh against it — ranked on the same six-factor Brief Score, top down.

Prefer a straight head-to-head? CoreAge Rx vs Luvo Health.

Our top alternative

No. 1 here

CoreAge Rx

One price on both molecules that does not climb as you titrate — but the headline $99 and $149 are annual-plan rates, paid in full up front.

Sema
$99/mo only on a 12-month plan paid in full ($1,188 in one charge); month-to-month rate not published
Tirz
$149/mo only on a 12-month plan paid in full ($1,788 in one charge); month-to-month rate not published
Coverage
US only; restrictions by state, confirmed at intake

More providers worth weighing

No. 101 · Grade C

RxSpan MD

72/100

One of the few providers in this ranking that names its pharmacies, its prescribers and their NPI numbers, and publishes every rung of both ladders — while its own API carries cheaper GLP-1 prices that no page will sell you.

Sema
$249/mo month-to-month, compounded — the funnel pre-selects a 3-month prepay at $657 up front, and its cheapest rung is $2,327 for a year in one charge
Coverage
All 50 states claimed — asynchronous review is not available in all of them
new to the tracker, no prior reading
No. 102 · Grade C

Care Bare Rx

72/100

Carries oral tirzepatide and a brand Ozempic lane, but prices nothing per molecule and nothing per dose.

Sema
$249/mo on the only semaglutide offer it publishes — a 3-month bundle from $748 in one charge; the site's headline "From $199/mo" is a floor shared across every weight-loss treatment, not a semaglutide rate · brand Ozempic from $705/mo
Coverage
All 50 states
price stable
No. 184 · Grade C

NuDay Rx

69/100

NuDay Rx is a GLP-1 weight-loss telehealth service (on the CareValidate/careGLP platform) that pairs medication with video coaching and lifestyle support.

Sema
From $249/mo (compounded)
Coverage
Coverage not published
new to the tracker, no prior reading
No. 171 · Grade C

Synergy Rx

67/100

One of the few providers in this ranking that names both its prescribers and its pharmacies — wrapped around an intro rate that steps up in month two, an $80 visit fee that appears in no headline, and an ODT bundle ladder that costs more per month than not bundling.

Sema
$249/mo ongoing, compounded ($199 first month only) + an $80 visit fee charged whether or not you get medication
Coverage
Coverage not published
new to the tracker, no prior reading
No. 147 · Grade C

Layla

71/100

Layla is a US telehealth weight-loss program built around semaglutide, offering compounded semaglutide as injections and as oral dropper drops, plus compounded tirzepatide.

Sema
From $237/mo (all doses, compounded)
Coverage
Coverage not published
new to the tracker, no prior reading
No. 190 · Grade C

CLYR Health

68/100

CLYR Health is a Florida-based telehealth pharmacy offering compounded GLP-1 weight-loss injections alongside sexual-health, longevity and wellness treatments.

Sema
From $229/mo (compounded)
Coverage
Coverage not published
new to the tracker, no prior reading
No. 35 · Grade B−

Found

81/100

The widest medication bench in the ranking — compounded, brand-name and oral orforglipron — priced off a membership rather than a sticker.

Sema
$289/mo cash month-to-month · $169/mo on a 12-month prepay paid up front ($2,028); the advertised $99 is the in-network INSURANCE rate and still sits before a ~$30 per-visit copay
Coverage
All 50 states
price stable
No. 37 · Grade B

Semaglutide Online

83/100

Semaglutide Online is a LegitScript-certified telehealth platform prescribing compounded and brand-name GLP-1/GIP medications nationwide (excluding Alabama).

Sema
From $199/mo (all doses, compounded)
Coverage
All 50 states
new to the tracker, no prior reading

Rankings reflect the Dose Brief Score — our editorial judgment per the methodology. Pricing and coverage reflect public disclosures at last review and change often — confirm on each provider's site. Not medical advice; see our disclosure.